A MULTICENTER PHASE I-II STUDY OF TOSEDOSTAT IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA

被引：0
|
作者：
Ossenkoppele, G. [1 ]
Hooftman, W. [2 ]
Zweegman, S. [1 ]
Davies, E. [3 ]
Morgan, G. [3 ]
Mueller-Tidow, C. [4 ]
Krug, U. [4 ]
Duhrsen, U. [4 ]
Burnett, A. [5 ]
Jenkins, C. [5 ]
Zachee, P. [6 ]
Dierickx, D. [4 ]
Lowenberg, B. [7 ]
Sonneveld, P. [7 ]
Hooftman, L. [2 ]
Richardson, A. [2 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Chroma Therapeut Ltd, Oxford, England
[3] Royal Marsden Hosp, London SW3 6JJ, England
[4] Univ Hosp, Munster, Germany
[5] Cardiff Univ Hosp, Cardiff, S Glam, Wales
[6] ZNA, Antwerp, Belgium
[7] Erasmus MC, Rotterdam, Netherlands
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1065
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [1] Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia
    DiNardo, Courtney D.
    Cortes, Jorge E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (02) : 265 - 272
  • [2] A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia
    Fiedler, Walter
    Chromik, Joerg
    Amberg, Stefanie
    Kebenko, Maxim
    Thol, Felicitas
    Schlipfenbacher, Vera
    Christine Wilke, Anne
    Modemann, Franziska
    Janning, Melanie
    Serve, Hubert
    Ganser, Arnold
    Bokemeyer, Carsten
    Theile, Susann
    Deppermann, Ute
    Kranich, Anne L.
    Heuser, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) : E169 - E173
  • [3] Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study
    Cortes, Jorge
    Feldman, Eric
    Yee, Karen
    Rizzieri, David
    Advani, Anjali S.
    Charman, Anthony
    Spruyt, Richard
    Toal, Martin
    Kantarjian, Hagop
    LANCET ONCOLOGY, 2013, 14 (04): : 354 - 362
  • [4] A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Abou Dalle, Iman
    Cortes, Jorge E.
    Pinnamaneni, Pramod
    Lamothe, Betty
    Duque, Adolfo Diaz
    Randhawa, Jasleen
    Pemmaraju, Naveen
    Jabbour, Elias
    Ferrajoli, Alessandra
    Wierda, William G.
    Estrov, Zeev
    Konopleva, Marina
    Ravandi, Farhad
    Alvarado, Yesid
    Borthakur, Gautam
    Gandhi, Varsha
    Kantarjian, Hagop M.
    ACTA HAEMATOLOGICA, 2018, 140 (01) : 30 - 39
  • [5] Treatment of relapsed/refractory acute myeloid leukaemia in adults
    Rashidi, Armin
    Weisdorf, Daniel J.
    Bejanyan, Nelli
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 27 - 37
  • [6] A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
    Canaani, Jonathan
    Danylesko, Ivetta
    Shemtov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 260 - 266
  • [7] A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Canaani, Jonathan
    Danilesko, Ivetta
    Shem-Tov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2020, 136
  • [8] A Phase I/II Study of Sapacitabine and Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia
    Desikan, Sai Prasad
    Kantarjian, Hagop
    DiNardo, Courtney D.
    Borthakur, Gautam
    Daver, Naval
    Pemmaraju, Naveen
    Alvarado, Yesid
    Burger, Jan A.
    Linderman, Debra Bull
    Pierce, Sherry A.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    BLOOD, 2021, 138
  • [9] Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study
    Fassas, A
    Buffels, R
    Anagnostopoulos, A
    Gacos, E
    Vadikolia, C
    Haloudis, P
    Kaloyannidis, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) : 308 - 315
  • [10] Phase I/II Clinical Study of Tosedostat, an Inhibitor of Aminopeptidases, in Patients With Acute Myeloid Leukemia and Myelodysplasia
    Lowenberg, Bob
    Morgan, Gareth
    Ossenkoppele, Gert J.
    Burnett, Alan K.
    Zachee, Pierre
    Duehrsen, Ulrich
    Dierickx, Daan
    Mueller-Tidow, Carsten
    Sonneveld, Pieter
    Krug, Utz
    Bone, Elisabeth
    Flores, Nicolas
    Richardson, Alison F.
    Hooftman, Leon
    Jenkins, Chris
    Zweegman, Sonja
    Davies, Faith
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) : 4333 - 4338
12345